SK13195A3 - Imidazole carboxylic acids and pharmaceutical agent containing thereof - Google Patents

Imidazole carboxylic acids and pharmaceutical agent containing thereof Download PDF

Info

Publication number
SK13195A3
SK13195A3 SK131-95A SK13195A SK13195A3 SK 13195 A3 SK13195 A3 SK 13195A3 SK 13195 A SK13195 A SK 13195A SK 13195 A3 SK13195 A3 SK 13195A3
Authority
SK
Slovakia
Prior art keywords
group
alkyl
formula
alkoxy
carbon atoms
Prior art date
Application number
SK131-95A
Other languages
English (en)
Slovak (sk)
Inventor
Robert J Ardecky
Carbl L Ensinger
James R Pruitt
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of SK13195A3 publication Critical patent/SK13195A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK131-95A 1992-08-06 1993-08-02 Imidazole carboxylic acids and pharmaceutical agent containing thereof SK13195A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/926,795 US5310929A (en) 1992-08-06 1992-08-06 Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
PCT/US1993/007103 WO1994003435A1 (en) 1992-08-06 1993-08-02 Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists

Publications (1)

Publication Number Publication Date
SK13195A3 true SK13195A3 (en) 1995-07-11

Family

ID=25453732

Family Applications (1)

Application Number Title Priority Date Filing Date
SK131-95A SK13195A3 (en) 1992-08-06 1993-08-02 Imidazole carboxylic acids and pharmaceutical agent containing thereof

Country Status (18)

Country Link
US (1) US5310929A (ja)
EP (1) EP0654027A1 (ja)
JP (1) JP2892838B2 (ja)
CN (1) CN1090275A (ja)
AU (1) AU688735B2 (ja)
BR (1) BR9306911A (ja)
CA (1) CA2141692C (ja)
FI (1) FI950485A0 (ja)
HU (1) HU9500349D0 (ja)
IL (1) IL106553A0 (ja)
MX (1) MX9304787A (ja)
NO (1) NO950404D0 (ja)
PL (1) PL307309A1 (ja)
SG (1) SG47108A1 (ja)
SK (1) SK13195A3 (ja)
TW (1) TW239131B (ja)
WO (1) WO1994003435A1 (ja)
ZA (1) ZA935693B (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
CA2111662C (en) * 1992-12-17 2004-11-23 Hiroaki Yanagisawa Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
HUT74734A (en) * 1994-03-16 1997-02-28 Sankyo Co Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity
US6221335B1 (en) * 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US5510495A (en) * 1994-09-19 1996-04-23 The Du Pont Merck Pharmaceutical Company Process for the isolation and purification of ester functionalized imidazole intermediates by selective hydrolysis
US5965738A (en) * 1994-09-20 1999-10-12 Wakunaga Seiyaku Kabushiki Kaisha Process for producing N-biphenylmethylthiadiazoline derivative or salt thereof and intermediate for producing the same
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
IT1295405B1 (it) * 1997-09-30 1999-05-12 Merck Sharp & Dohme Italia S P Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di
DE19820064A1 (de) * 1998-05-06 1999-11-11 Hoechst Marion Roussel De Gmbh Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
DE19832428A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832429A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ES2154191B1 (es) * 1998-11-24 2001-10-16 Ferrer Int Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
AU2002257970B2 (en) 2001-05-31 2007-08-02 Vicore Pharma Ab Tricyclic compounds useful as angiotensin II agonists
CN101165062A (zh) * 2003-01-16 2008-04-23 特瓦制药工业有限公司 伊贝沙坦的新合成方法
JP4779067B2 (ja) 2004-01-20 2011-09-21 愛知県 ＨＬＡ−Ａ２４０２拘束性Ｅｐ−ＣＡＭ特異的ＣＴＬが認識するエピトープ・ペプチド及びその用途
US7157584B2 (en) * 2004-02-25 2007-01-02 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
CA2575177A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Purification of olmesartan medoxomil
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
CA2604190A1 (en) * 2005-04-20 2006-11-02 Merck & Co., Inc. Angiotensin ii receptor antagonists
EP1931648A2 (en) * 2006-08-29 2008-06-18 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of 5-phenyl -1 trityl-1h-tetrazole
AU2007306171B2 (en) * 2006-10-09 2013-02-21 Cipla Limited Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
AU2006351517B8 (en) * 2006-12-06 2012-01-19 Shenzhen Salubris Pharmaceuticals Co., Ltd. The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof
US9107911B2 (en) 2010-01-07 2015-08-18 Alkermes Pharma Ireland Limited Prodrugs of heteraromatic compounds
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
CN111018841B (zh) * 2013-11-01 2023-04-07 深圳信立泰药业股份有限公司 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物
US20220257698A1 (en) 2019-08-02 2022-08-18 Lanthiopep B.V. Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
EP0479892A1 (en) * 1989-06-30 1992-04-15 E.I. Du Pont De Nemours And Company Fused-ring aryl substituted imidazoles
WO1991000277A1 (en) * 1989-06-30 1991-01-10 E.I. Du Pont De Nemours And Company Substituted imidazoles
GB8927277D0 (en) * 1989-12-01 1990-01-31 Glaxo Group Ltd Chemical compounds
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5137902A (en) * 1990-07-13 1992-08-11 E. I. Du Pont De Nemours And Company 4-alkylimidazole derivatives and anti-hypertensive use thereof
DK0573218T3 (da) * 1992-06-02 2001-06-18 Sankyo Co 4-carboxyimidazolderivater som angiotensin-II antagonister og deres terapeutiske anvendelse

Also Published As

Publication number Publication date
PL307309A1 (en) 1995-05-15
EP0654027A1 (en) 1995-05-24
CA2141692C (en) 2006-05-30
FI950485A (fi) 1995-02-03
JP2892838B2 (ja) 1999-05-17
SG47108A1 (en) 1998-03-20
FI950485A0 (fi) 1995-02-03
ZA935693B (en) 1995-02-06
WO1994003435A1 (en) 1994-02-17
TW239131B (ja) 1995-01-21
HU9500349D0 (en) 1995-03-28
NO950404D0 (no) 1995-02-03
CA2141692A1 (en) 1994-02-17
CN1090275A (zh) 1994-08-03
AU688735B2 (en) 1998-03-19
IL106553A0 (en) 1993-12-08
AU4790393A (en) 1994-03-03
JPH08500103A (ja) 1996-01-09
BR9306911A (pt) 1998-12-08
MX9304787A (es) 1995-01-31
US5310929A (en) 1994-05-10

Similar Documents

Publication Publication Date Title
SK13195A3 (en) Imidazole carboxylic acids and pharmaceutical agent containing thereof
FI114983B (fi) Menetelmä bentsimidatsoli-7-karboksylaatin C-tyyppiä olevan kiteen valmistamiseksi
JP2550442B2 (ja) 置換イミダゾール
FI99012C (fi) Menetelmä antihypertensiivisten imidatsolijohdannaisten valmistamiseksi
US5162326A (en) Pyrimidinedione derivatives, their production and use
FI102610B (fi) Menetelmä farmakologisesti aktiivisten imidatsolyylialkeenihappojen va lmistamiseksi
KR900005045B1 (ko) 앤지오텐신 ii수용체 차단 이미다졸
JP2568315B2 (ja) 縮合環アリール置換イミダゾール
US5703110A (en) Benzimidazole derivatives, their production and use
SK279004B6 (sk) 2,6-substituovaná 3-[[2'-(1h-tetrazol-5-yl)[1,1'-b
WO1992007834A1 (en) N-substituted imidazol-2-one compounds for treatment of circulatory disorders
CS9100906A2 (en) Substituted azoles, method of their production, preparations that contain these compounds and their application
US6232334B1 (en) Benzimidazole derivatives, their production and use
EP0690854B1 (en) 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders
JP3032844B2 (ja) ピリミジンジオン誘導体
RU2144022C1 (ru) Эфиры n-(бифенилметил)аминобензойной кислоты и способ их получения
KR20100110438A (ko) 올메살탄의 신규한 에스테르 화합물, 이의 중간체, 이의 제조방법 및 이를 포함하는 조성물
WO2000031071A1 (en) 2-alkyl-5-halo-3-[2'-(tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-imidazole-4-carboxaldehyde acetal derivatives, their preparation and use
HU218201B (hu) Eljárás angiotenzin II receptor blokkoló imidazol-származékok, valamint ezeket tartalmazó gyógyászati készítmények előállítására
HUT69701A (en) 3-(quinolin-6-yl-methyl)-4h-imidazol-4-one derivatives and their preparation
JPH0625231A (ja) イソインダゾール誘導体
CZ289405B6 (cs) Benzimidazolové deriváty, způsob jejich výroby, farmaceutický prostředek je obsahující a intermediáty pro jejich výrobu
WO1994004510A1 (en) Pyridazine derivative
IL95259A (en) Substituted n-aryl and -aralkyl-imidazoles, their preparation and pharmaceutical compositions containing them.